Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 110 participants.

Also called NCT05711849

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 110 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05711849
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05711849. Randomized; double masking; primary purpose treatment. Start 2024-03-01 (actual); primary completion 2026-08-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
Acronym
RegenCobra
Condition
Refractory Angina Pectoris
Condition
Refractory Angina
Intervention (Biological)
Bone marrow aspiration and a single intracoronary infusion of autologous bone marrow-derived mononuclear cells.
Intervention (Procedure)
Sham bone marrow aspiration and sham cell infusion (insertion of vascular access sheath).
Lead sponsor
Barts & The London NHS Trust (class: other)

Record details

Record id
cardio:ct-nct05711849
Content hash
78caefd7ef01fcc9af29856cd138861b90f0c247ef2dc72df31445384f8a5578